Position in GILD
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$1,130,237
-$167,994 QoQ
Shares Held
8,946
-4.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1,020
of 2,266 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Midwest Trust Co holds $426,400,690 across 11 Drug Manufacturers - General names. GILD ranks #10 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
489,495 | $123,176,521 | |
| 2 | MRK |
Merck & Co., Inc.
|
738,473 | $94,893,780 | |
| 3 | LLY |
ELI LILLY & Co
|
68,243 | $81,852,708 | |
| 4 | JNJ |
Johnson & Johnson
|
160,444 | $40,747,962 | |
| 5 | NVS |
Novartis AG
|
239,181 | $37,484,446 | |
| 6 | AMGN |
Amgen Inc
|
77,424 | $28,036,778 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
118,188 | $6,809,992 | |
| 8 | GSK |
GSK plc
|
119,518 | $6,265,133 |
All Filings in GILD
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,130,237 | 8,946 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $1,298,231 | 9,315 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $1,354,558 | 11,036 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $1,011,543 | 9,113 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $993,949 | 8,965 | Shares | Sole | 2025-08-07 | |
| No filing history on record for this holder in this stock. | ||||||